105
Participants
Start Date
February 27, 2001
Primary Completion Date
March 17, 2005
Study Completion Date
August 15, 2006
imatinib mesylate
Memorial Sloan-Kettering Cancer Center, New York
Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh
University of Wisconsin Comprehensive Cancer Center, Madison
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
UCSF Comprehensive Cancer Center, San Francisco
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
University of Michigan Comprehensive Cancer Center, Ann Arbor
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas
University of Texas - MD Anderson Cancer Center, Houston
University of Texas Health Science Center at San Antonio, San Antonio
National Cancer Institute (NCI)
NIH
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER